Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 471,046
  • Shares Outstanding, K 273,864
  • Annual Sales, $ 200,520 K
  • Annual Income, $ -306,740 K
  • EBIT $ -296 M
  • EBITDA $ -282 M
  • 60-Month Beta 2.01
  • Price/Sales 2.14
  • Price/Cash Flow N/A
  • Price/Book 0.94

Options Overview Details

View History
  • Implied Volatility 96.51% ( -12.63%)
  • Historical Volatility 125.02%
  • IV Percentile 40%
  • IV Rank 21.13%
  • IV High 199.73% on 08/22/24
  • IV Low 68.86% on 11/28/23
  • Put/Call Vol Ratio 0.02
  • Today's Volume 827
  • Volume Avg (30-Day) 7,201
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 138,834
  • Open Int (30-Day) 116,604

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.20
  • Number of Estimates 4
  • High Estimate -0.16
  • Low Estimate -0.28
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +25.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4900 +15.44%
on 11/19/24
2.7200 -36.76%
on 11/07/24
-0.2600 (-13.13%)
since 10/18/24
3-Month
1.2700 +35.43%
on 09/05/24
2.7200 -36.76%
on 11/07/24
+0.2300 (+15.44%)
since 08/20/24
52-Week
1.1600 +48.28%
on 07/02/24
10.6500 -83.85%
on 12/27/23
-6.8600 (-79.95%)
since 11/20/23

Most Recent Stories

More News
Deciphering Disruption: Inside Cathie Wood's Latest Plays

Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.

GH : 30.68 (unch)
CRSP : 47.26 (+0.62%)
TSLA : 342.03 (-1.15%)
PACB : 1.7200 (unch)
TTD : 123.90 (+3.75%)
U : 21.63 (+9.24%)
MRNA : 36.94 (-0.94%)
AMZN : 202.88 (-0.85%)
COIN : 320.01 (-1.40%)
SQ : 89.70 (-2.94%)
PLTR : 62.12 (-1.37%)
ARKK : 55.28 (-1.14%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The rock star money manager is starting to roll with the rallying market.

GH : 30.68 (unch)
TTD : 123.90 (+3.75%)
PACB : 1.7200 (unch)
PacBio to Present at Upcoming Investor Conferences

PACB : 1.7200 (unch)
Pacific Biosciences: Q3 Earnings Snapshot

Pacific Biosciences: Q3 Earnings Snapshot

PACB : 1.7200 (unch)
PacBio Announces Third Quarter 2024 Financial Results

PACB : 1.7200 (unch)
PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028

PACB : 1.7200 (unch)
PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop

PACB : 1.7200 (unch)
PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500

PACB : 1.7200 (unch)
PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program

PACB : 1.7200 (unch)
PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing

PACB : 1.7200 (unch)

Business Summary

Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time...

See More

Key Turning Points

3rd Resistance Point 1.9133
2nd Resistance Point 1.8467
1st Resistance Point 1.7833
Last Price 1.7200
1st Support Level 1.6533
2nd Support Level 1.5867
3rd Support Level 1.5233

See More

52-Week High 10.6500
Fibonacci 61.8% 7.0248
Fibonacci 50% 5.9050
Fibonacci 38.2% 4.7852
Last Price 1.7200
52-Week Low 1.1600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar